RHT is worth over $100 million $28c now with its A1 world approved roll out , as good as an investment as you can get , look at what you have invested in .
A WIDE SUITE OF SERVICES AVAILABLE Resonance Health has recently increased its product suite with the inclusion of several new assessment techniques such as NASHScan (mentioned above),
NAFLDGenotyping (genetic risk factor analysis for NAFLD), and PDFFScan (standardised solution for the measurement of fat in all segments of hepatic tissue) to assist clinicians in diagnosing and managing conditions. Resonance Health also offers the following additional services, including:
• Bone Marrow R2-MRI for Iron Assessment - provides a non-invasive assessment of iron levels in the bone marrow. Available for clinical use in the EU and Australia, and for investigational use in study settings in the USA. Bone Marrow R2-MRI may provide additional valuable data as conjunct/replacement for bone marrow aspirates to measure changes in underlying bone marrow iron deposition.
• Quantitative Iron Assessment in Other Organs - surrogate iron measurements (R2 / R2*) in other organs including pancreas, spleen, and kidney.
• Organ Volume Measurements - volume measurements of various organs e.g. liver and spleen.
• Liver Biopsy – Stereology Services - quantitative assessment of hepatic steatosis of digitized biopsies using stereology.
• Pancreatic Fat Assessment - quantitative assessment of pancreatic fat.
• Visceral / Subcutaneous Fat and Organ Fat in Metabolic Disease - quantitative assessments of visceral fat, s
- Forums
- Charts
- Chart
RHT is worth over $100 million $28c now with its A1 world...
-
- There are more pages in this discussion • 3,385 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RHT (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.0¢ |
Change
0.005(7.69%) |
Mkt cap ! $31.28M |
Open | High | Low | Value | Volume |
6.6¢ | 7.2¢ | 6.6¢ | $14.65K | 213.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 39048 | 6.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.0¢ | 16592 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 39048 | 0.066 |
1 | 200000 | 0.063 |
1 | 35000 | 0.060 |
2 | 45719 | 0.056 |
2 | 346247 | 0.055 |
Price($) | Vol. | No. |
---|---|---|
0.070 | 16592 | 1 |
0.072 | 64303 | 2 |
0.073 | 4007 | 2 |
0.075 | 193000 | 2 |
0.078 | 59045 | 2 |
Last trade - 13.47pm 29/03/2024 (20 minute delay) ? |
|
|||||
Last
7.0¢ |
  |
Change
0.005 ( 2.94 %) |
|||
Open | High | Low | Volume | ||
7.2¢ | 7.2¢ | 6.6¢ | 150749 | ||
Last updated 13.26pm 29/03/2024 ? |
Featured News
RHT (ASX) Chart |
The Watchlist
BGD
BARTON GOLD HOLDINGS LIMITED
Alex Scanlon, Managing Director & CEO
Alex Scanlon
Managing Director & CEO
SPONSORED BY The Market Online